Norepinephrine Bitartrate Injection, Solution
Product Images NDC 25021-316

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 25021-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Nor0m 0001 01)

Structural Formula (Nor0m 0001 01)
Chemical structure diagram showing the molecular composition of Norepinephrine Bitartrate with a water molecule (H2O) indicated.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Nor0m 0001 02)

Package Label – Principal Display Panel – Vial Label (Nor0m 0001 02)
Norepinephrine Bitartrate Injection, USP 4 mg per 4 mL (1 mg per mL) sterile, nonpyrogenic, preservative-free solution for intravenous infusion. Single-dose vial. Label indicates storage instructions, warnings, and manufacturer information: Sagent Pharmaceuticals, Schaumburg, IL, made in India. Includes barcode and lot/expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.